Mankind Pharma Limited (BOM:543904)

Mankind Pharma Statistics

Total Valuation

Mankind Pharma has a market cap or net worth of INR 980.71 billion. The enterprise value is 1.02 trillion.

Market Cap	980.71B
Enterprise Value	1.02T

Important Dates

The last earnings date was Tuesday, May 19, 2026.

Earnings Date	May 19, 2026
Ex-Dividend Date	Aug 8, 2025

Share Statistics

Current Share Class	412.83M
Shares Outstanding	n/a
Shares Change (YoY)	+2.13%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	57.71%
Owned by Institutions (%)	22.16%
Float	112.83M

Valuation Ratios

The trailing PE ratio is 51.27 and the forward PE ratio is 41.34.

PE Ratio	51.27
Forward PE	41.34
PS Ratio	6.87
PB Ratio	5.92
P/TBV Ratio	588.66
P/FCF Ratio	39.30
P/OCF Ratio	31.42
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.21, with an EV/FCF ratio of 41.03.

EV / Earnings	53.52
EV / Sales	7.17
EV / EBITDA	28.21
EV / EBIT	37.32
EV / FCF	41.03

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.38.

Current Ratio	1.07
Quick Ratio	0.61
Debt / Equity	0.38
Debt / EBITDA	1.74
Debt / FCF	2.53
Interest Coverage	4.27

Financial Efficiency

Return on equity (ROE) is 12.45% and return on invested capital (ROIC) is 11.07%.

Return on Equity (ROE)	12.45%
Return on Assets (ROA)	6.11%
Return on Invested Capital (ROIC)	11.07%
Return on Capital Employed (ROCE)	12.66%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	7.28M
Profits Per Employee	974,990
Employee Count	19,620
Asset Turnover	0.51
Inventory Turnover	1.91

Taxes

In the past 12 months, Mankind Pharma has paid 3.95 billion in taxes.

Income Tax	3.95B
Effective Tax Rate	16.92%

Stock Price Statistics

The stock price has decreased by -3.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-3.88%
50-Day Moving Average	2,232.02
200-Day Moving Average	2,287.60
Relative Strength Index (RSI)	44.76
Average Volume (20 Days)	131,560

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mankind Pharma had revenue of INR 142.78 billion and earned 19.13 billion in profits. Earnings per share was 46.28.

Revenue	142.78B
Gross Profit	102.26B
Operating Income	27.31B
Pretax Income	23.33B
Net Income	19.13B
EBITDA	36.17B
EBIT	27.31B
Earnings Per Share (EPS)	46.28

Balance Sheet

The company has 22.68 billion in cash and 63.12 billion in debt, with a net cash position of -40.44 billion.

Cash & Cash Equivalents	22.68B
Total Debt	63.12B
Net Cash	-40.44B
Net Cash Per Share	n/a
Equity (Book Value)	165.61B
Book Value Per Share	395.20
Working Capital	4.47B

Cash Flow

In the last 12 months, operating cash flow was 31.21 billion and capital expenditures -6.26 billion, giving a free cash flow of 24.95 billion.

Operating Cash Flow	31.21B
Capital Expenditures	-6.26B
Depreciation & Amortization	8.86B
Net Borrowing	-22.64B
Free Cash Flow	24.95B
FCF Per Share	n/a

Margins

Gross margin is 71.62%, with operating and profit margins of 19.13% and 13.40%.

Gross Margin	71.62%
Operating Margin	19.13%
Pretax Margin	16.34%
Profit Margin	13.40%
EBITDA Margin	25.34%
EBIT Margin	19.13%
FCF Margin	17.48%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.04%.

Dividend Per Share	1.00
Dividend Yield	0.04%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	2.16%
Buyback Yield	-2.13%
Shareholder Yield	-2.09%
Earnings Yield	1.95%
FCF Yield	2.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6